Humana Inc. (HUM) Key Metrics
HUM valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $49.61B
- Enterprise value
- $56.56B
- P/E (TTM)
- 39.1 10-yr median 23.0
- Forward P/E
- 24.3
- PEG ratio
- 1.25
- Price / sales
- 0.3 10-yr median 0.7
- Price / book
- 2.3 10-yr median 3.7
- EV / EBITDA
- — 10-yr median 13.6
- Dividend yield
- 0.86% $3.54 a year
- Beta
- 0.74
HUM key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsHUM valuation Price multiples at each fiscal year-end price.
HUM returns How much profit the business earns on the capital it uses.
HUM per-share figures Results divided by the shares outstanding at year-end.
HUM financial health Debt, liquidity and how easily interest is covered.
HUM efficiency & capital use Working capital cycle and where the cash goes.
HUM valuation history
HUM returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HUM debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HUM cash returned to shareholders
HUM price vs earnings per share
HUM key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $30.95B | $30.67B | $56.97B | $65.10B | $60.02B | $54.57B | $49.38B | $39.65B | $36.12B | $30.79B |
| Enterprise value | $39.68B | $40.70B | $64.55B | $71.79B | $69.85B | $57.04B | $51.44B | $43.38B | $36.99B | $31.01B |
| P/E ratio | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 |
| Price / sales | 0.2 | 0.3 | 0.5 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 |
| Price / book | 1.8 | 1.9 | 3.5 | 4.3 | 3.7 | 4.0 | 4.1 | 3.9 | 3.7 | 2.9 |
| Price / free cash flow | 82.5 | 12.8 | 19.1 | 18.8 | 63.4 | 11.7 | 10.9 | 25.4 | 10.2 | 21.9 |
| Price / operating cash flow | 33.6 | 10.3 | 14.3 | 14.2 | 26.5 | 9.7 | 9.3 | 18.2 | 8.9 | 15.9 |
| EV / sales | 0.3 | 0.3 | 0.6 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.7 | 0.6 |
| EV / EBITDA | 13.6 | 12.5 | 13.6 | 14.9 | 15.7 | 10.2 | 12.0 | 15.3 | — | 14.1 |
| EV / free cash flow | 105.8 | 17.0 | 21.7 | 20.7 | 73.8 | 12.2 | 11.3 | 27.8 | 10.5 | 22.0 |
| Earnings yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% |
| Free cash flow yield | 1.2% | 7.8% | 5.2% | 5.3% | 1.6% | 8.6% | 9.2% | 3.9% | 9.8% | 4.6% |
| Dividend yield | 1.4% | 1.4% | 0.8% | 0.6% | 0.6% | 0.6% | 0.6% | 0.7% | 0.6% | 0.6% |
| Shareholder yield (dividends + buybacks) | 1.9% | 4.1% | 3.5% | 3.8% | 0.7% | 3.9% | 2.8% | 3.4% | 9.9% | 0.9% |
| Share price at fiscal year-end | $256.13 | $253.71 | $457.81 | $512.19 | $463.86 | $410.27 | $366.52 | $286.48 | $248.07 | $204.03 |
| Per share | ||||||||||
| Revenue per share | $1,073.15 | $974.70 | $855.35 | $731.13 | $646.45 | $580.33 | $481.96 | $411.44 | $369.54 | $360.50 |
| Earnings per share | $9.83 | $9.99 | $20.00 | $22.08 | $22.67 | $25.31 | $20.09 | $12.16 | $16.81 | $4.07 |
| Operating cash flow per share | $7.62 | $24.54 | $31.99 | $36.09 | $17.48 | $42.39 | $39.22 | $15.70 | $27.83 | $12.83 |
| Free cash flow per share | $3.10 | $19.78 | $23.92 | $27.28 | $7.31 | $35.15 | $33.76 | $11.28 | $24.21 | $9.34 |
| Cash per share | $34.76 | $18.38 | $37.72 | $39.82 | $26.23 | $35.13 | $30.09 | $16.93 | $27.76 | $25.69 |
| Book value per share | $146.14 | $135.48 | $130.68 | $120.47 | $124.27 | $103.21 | $89.34 | $73.42 | $67.60 | $70.80 |
| Tangible book value per share | $56.64 | $43.86 | $40.33 | $34.65 | $18.15 | $67.30 | $58.87 | $43.49 | $43.51 | $47.26 |
| Dividends per share | $3.56 | $3.57 | $3.46 | $3.08 | $2.74 | $2.43 | $2.16 | $1.91 | $1.51 | $1.17 |
| Capex per share | $4.52 | $4.76 | $8.07 | $8.81 | $10.17 | $7.25 | $5.46 | $4.42 | $3.61 | $3.49 |
| Debt per share | $107.07 | $101.43 | $98.59 | $92.47 | $102.21 | $53.71 | $45.38 | $43.85 | $33.79 | $27.11 |
| Shares outstanding | 120.8M | 120.9M | 124.4M | 127.1M | 129.4M | 133.0M | 134.7M | 138.4M | 145.6M | 150.9M |
| Change in shares outstanding | −0.0% | −2.9% | −2.1% | −1.8% | −2.7% | −1.3% | −2.7% | −4.9% | −3.5% | −0.1% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 7.0% | 7.4% | 15.8% | 17.9% | 19.7% | 26.1% | 24.4% | 16.8% | 23.9% | 5.8% |
| Return on invested capital (ROIC) | 4.6% | 4.8% | 10.8% | 11.7% | 13.9% | 22.2% | 19.3% | 13.7% | 18.7% | 7.6% |
| Return on assets (ROA) | 2.5% | 2.6% | 5.5% | 6.3% | 7.3% | 10.5% | 10.0% | 6.5% | 9.3% | 2.4% |
| Return on tangible assets | 3.1% | 3.4% | 7.0% | 8.6% | 9.5% | 11.1% | 10.9% | 7.9% | 10.6% | 2.8% |
| Free cash flow margin | 0.3% | 2.0% | 2.8% | 3.7% | 1.1% | 6.1% | 7.0% | 2.7% | 6.6% | 2.6% |
| Income quality (OCF / net income) | 0.78 | 2.46 | 1.60 | 1.63 | 0.77 | 1.67 | 1.95 | 1.29 | 1.65 | 3.15 |
| Financial health | ||||||||||
| Total debt | $12.94B | $12.26B | $12.27B | $11.75B | $13.22B | $7.14B | $6.11B | $6.07B | $4.92B | $4.09B |
| Cash & short-term investments | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B |
| Net debt | $8.74B | $10.04B | $7.58B | $6.69B | $9.83B | $2.47B | $2.06B | $3.73B | $878.0M | $215.0M |
| Debt / equity | 0.73 | 0.75 | 0.75 | 0.77 | 0.82 | 0.52 | 0.51 | 0.60 | 0.50 | 0.38 |
| Debt / assets | 0.27 | 0.26 | 0.26 | 0.27 | 0.30 | 0.20 | 0.21 | 0.24 | 0.18 | 0.16 |
| Net debt / EBITDA | 3.00 | 3.08 | 1.60 | 1.39 | 2.21 | 0.44 | 0.48 | 1.32 | — | 0.10 |
| Current ratio | 0.72 | 0.44 | 0.56 | 0.58 | 0.50 | 0.65 | 0.75 | 0.51 | 1.12 | 0.86 |
| Quick ratio | 0.72 | 0.44 | 3.24 | 2.97 | 3.04 | 3.40 | 3.83 | 1.06 | 1.12 | 0.86 |
| Interest coverage | 2.3 | 2.5 | 6.7 | 8.9 | 10.5 | 16.5 | 14.3 | 9.5 | 13.7 | 9.2 |
| Working capital | −$2.84B | −$6.33B | −$5.22B | −$4.90B | −$5.29B | −$3.19B | −$1.69B | −$3.17B | $524.0M | −$747.0M |
| Invested capital | $26.39B | $26.41B | $23.84B | $22.00B | $25.91B | $16.20B | $14.10B | $13.89B | $10.72B | $10.90B |
| Tangible asset value | $6.92B | $5.37B | $5.08B | $4.46B | $2.37B | $8.95B | $7.93B | $6.02B | $6.33B | $7.13B |
| Net current asset value | −$23.54B | −$24.94B | −$23.84B | −$21.62B | −$23.44B | −$15.54B | −$11.90B | −$11.82B | −$11.95B | −$10.43B |
| Graham number | $179.80 | $174.47 | $242.51 | $244.63 | $251.75 | $242.45 | $200.97 | $141.73 | $159.93 | $80.51 |
| Graham net-net per share | −$201.62 | −$211.95 | −$324.36 | −$283.00 | −$287.83 | −$212.10 | −$167.98 | −$100.15 | −$83.52 | −$68.18 |
| Capital allocation | ||||||||||
| Dividends paid | $430.0M | $431.0M | $431.0M | $392.0M | $354.0M | $323.0M | $291.0M | $265.0M | $220.0M | $177.0M |
| Share buybacks (net) | $151.0M | $817.0M | $1.57B | $2.10B | $79.0M | $1.82B | $1.07B | $1.09B | $3.37B | $104.0M |
| Dividend payout ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.7% | 15.7% | 9.0% | 28.8% |
| Dividends + buybacks / free cash flow | 154.9% | 52.2% | 67.3% | 71.8% | 45.8% | 45.8% | 29.9% | 86.8% | 101.7% | 19.9% |
| Capex / revenue | 0.4% | 0.5% | 0.9% | 1.2% | 1.6% | 1.2% | 1.1% | 1.1% | 1.0% | 1.0% |
| Capex / operating cash flow | 59.3% | 19.4% | 25.2% | 24.4% | 58.2% | 17.1% | 13.9% | 28.2% | 13.0% | 27.2% |
| Capex / depreciation | 0.66 | 0.59 | 1.09 | 1.33 | 1.85 | 1.56 | 1.28 | 1.15 | 1.08 | 1.13 |
| Stock-based compensation / revenue | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.2% | 0.3% | 0.2% |
| SG&A / revenue | 0.2% | 0.2% | 0.2% | — | 12.1% | 13.0% | 11.4% | 13.2% | 12.2% | 13.4% |
| Efficiency | ||||||||||
| Days sales outstanding | 8.4 | 7.3 | 6.4 | 6.9 | 6.4 | 5.2 | 5.8 | 6.0 | 7.2 | 8.2 |
| Days of inventory on hand | — | — | -123.6 | -131.6 | -135.8 | -135.7 | -83.2 | -14.2 | — | — |
| Days payables outstanding | 33.1 | 36.9 | 39.5 | 41.4 | 42.3 | 40.6 | 34.9 | 33.5 | 35.4 | 38.8 |
| Cash conversion cycle (days) | -24.7 | -29.5 | -156.8 | -166.1 | -171.7 | -171.1 | -112.3 | -41.7 | -28.1 | -30.6 |
| Receivables turnover | 43.41 | 49.72 | 57.40 | 53.28 | 56.67 | 70.37 | 62.71 | 60.94 | 50.42 | 44.58 |
| Payables turnover | 11.04 | 9.90 | 9.23 | 8.81 | 8.62 | 8.99 | 10.45 | 10.90 | 10.32 | 9.41 |
| Asset turnover | 2.73 | 2.53 | 2.35 | 2.10 | 2.10 | 2.41 | 2.39 | 2.19 | 2.05 | 2.14 |
| Average receivables | $2.99B | $2.37B | $1.85B | $1.74B | $1.48B | $1.10B | $1.04B | $934.5M | $1.07B | $1.22B |
| Average payables | $10.04B | $10.17B | $9.58B | $8.59B | $8.03B | $6.84B | $5.14B | $4.20B | $4.20B | $4.77B |
| Average inventory | — | — | −$29.94B | −$27.28B | −$25.74B | −$22.86B | −$12.25B | −$1.78B | $0 | $0 |
| Intangibles / total assets | 22.2% | 23.9% | 24.0% | 24.9% | 30.7% | 13.6% | 14.1% | 16.3% | 13.1% | 13.8% |
Computed from HUM's annual financial statements (latest annual report filed February 19, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HUM valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Humana traded at 26.0 times earnings, against a 10-year median of 23.0. Based on the latest twelve months, the trailing P/E is 39.1 and the forward P/E is 24.3. Humana earned a return on equity of 7.0% and a return on invested capital of 4.6% in fiscal 2025. It ended the year with $12.9 billion of debt and $4.2 billion in cash and short-term investments, net debt of $8.7 billion. It returned $581.0 million to shareholders: $430.0 million in dividends and $151.0 million in share buybacks, 155% of free cash flow. The share count fell 19.9% from 150.9M to 120.8M over 9 years.
See the HUM income statement, the HUM chart for price history, or the HUM stock overview for the latest quote and news.
HUM key metrics FAQ
What is Humana's P/E ratio?
Humana's trailing P/E ratio is 39.1 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 24.3. At the end of fiscal 2025 it was 26.0, compared with a 10-year median of 23.0.
What is Humana's EV/EBITDA?
Humana's enterprise value was 13.6 times EBITDA at the end of fiscal 2025 (enterprise value $39.7 billion, EBITDA $2.9 billion).
What is Humana's return on equity?
Humana's return on equity (ROE) was 7.0% in fiscal 2025: net income of $1.2 billion on average shareholders' equity of $17.0 billion.
What is Humana's ROIC?
Humana's return on invested capital was 4.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Humana have?
Humana had total debt of $12.9 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.73 and $8.7 billion of net debt (3.00 times EBITDA).
What is Humana's dividend yield?
Humana's forward dividend yield is 0.86%. Humana paid $430.0 million in dividends in fiscal 2025 ($3.56 per share), a payout ratio of 36.2%.
Does Humana buy back its shares?
Yes. Humana spent $151.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.0% over the year, to 120.8M..
What is Humana's free cash flow yield?
Humana generated $375.0 million of free cash flow in fiscal 2025, a free cash flow yield of 1.2% on its market value at year-end ($30.9 billion).
What is Humana's current ratio?
Humana's current ratio was 0.72 at the end of fiscal 2025: current assets were 0.72 times current liabilities.